Oxycodone Injectable Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution (IM/IV)
Available Strengths: 10 mg/mL or 20 mg/mL in vials
Reference Brands: OxyContin, Roxicodone, Oxymorphone(US); OxyContin, OxyNorm(EU)
Category:
Analgesic
Oxycodone injectable activates mu-opioid receptors in the brain and spinal cord, blocking pain signals and altering pain perception. Benefits include rapid, potent pain relief in hospital settings, especially post-surgery or severe pain cases, providing short-term, effective analgesia when other routes are unsuitable, with careful regulation due to dependence risks
Oxycodone injectable is available in Injectable Solution (IM/IV)
and strengths such as 10 mg/mL or 20 mg/mL in vials.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Oxycodone injectable is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Oxycodone injectable can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Oxycodone injectable is primarily used for research or hospital settings and is not widely marketed for general clinical use. Due to its high abuse potential and strict control, injectable oxycodone is regulated as a controlled substance in both the US and EU. In the US, such formulations are regulated by the DEA and FDA, requiring special licenses, and are typically available only for limited clinical or research purposes. In the EU, approval and manufacturing are overseen by EMA, with strict regulatory controls, including licensing, risk management, and pharmacovigilance. For detailed regulatory support, dossier preparation, and compliance, visit PharmaTradz. We help facilitate adherence to regulations for restricted opioid formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing